Cargando…

Differential effects of dopaminergic drugs on spontaneous motor activity in the common marmoset following pretreatment with a bilateral brain infusion of 6-hydroxydopamine

The differential effects of dopaminergic drugs with different pharmacological profiles were investigated with respect to spontaneous motor activity in the common marmoset following pretreatment with a bilateral brain infusion of 6-hydroxydopamine (6-OHDA). Three marmosets received infusions of 6-OHD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ando, Kiyoshi, Nishime, Chiyoko, Inoue, Ryo, Nishinaka, Eiko, Kawai, Kenji, Urano, Koji, Tsutsumi, Hideki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams and Wilkins 2017
Materias:	Research Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5690296/ https://www.ncbi.nlm.nih.gov/pubmed/29099404 http://dx.doi.org/10.1097/FBP.0000000000000353

Ejemplares similares

Measurement of baseline locomotion and other behavioral traits in a common marmoset model of Parkinson's disease established by a single administration regimen of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: providing reference data for efficacious preclinical evaluations
por: Ando, Kiyoshi, et al.
Publicado: (2020)

Transplantation of Chemical Compound-Induced Cells from Human Fibroblasts Improves Locomotor Recovery in a Spinal Cord Injury Rat Model
por: Kurahashi, Toshihiro, et al.
Publicado: (2023)

PET Analysis of Dopaminergic Neurodegeneration in Relation to Immobility in the MPTP-Treated Common Marmoset, a Model for Parkinson’s Disease
por: Ando, Kiyoshi, et al.
Publicado: (2012)

Alleviation of Methamphetamine Sensitization by Partially Lesioning Dopaminergic Terminals with 6-Hydroxydopamine in Nucleus Accumbens
por: Chen, Shu-Chun, et al.
Publicado: (2021)

rasH2 mouse: reproducibility and stability of carcinogenicity due to a standardized production and monitoring system
por: Tsutsumi, Hideki, et al.
Publicado: (2021)

Achyranthes bidentata polypeptide protects dopaminergic neurons from apoptosis induced by rotenone and 6-hydroxydopamine
por: Peng, Su, et al.
Publicado: (2018)

Protective Effect of Amber Extract on Human Dopaminergic Cells against 6-Hydroxydopamine-Induced Neurotoxicity
por: Luo, Yuening, et al.
Publicado: (2022)

6-Hydroxydopamine induces secretion of PARK7/DJ-1 via autophagy-based unconventional secretory pathway
por: Urano, Yasuomi, et al.
Publicado: (2018)

Destruction of Dopaminergic Neurons in the Midbrain by 6-Hydroxydopamine Decreases Hippocampal Cell Proliferation in Rats: Reversal by Fluoxetine
por: Suzuki, Katsuaki, et al.
Publicado: (2010)

Erythropoietin improves neurobehavior by reducing dopaminergic neuron loss in a 6-hydroxydopamine-induced rat model
por: QI, CHEN, et al.
Publicado: (2014)

Abrogation of the Circadian Nuclear Receptor REV-ERBα Exacerbates 6-Hydroxydopamine-Induced Dopaminergic Neurodegeneration
por: Kim, Jeongah, et al.
Publicado: (2018)

Prosaposin PS18 reduces dopaminergic neurodegeneration in a 6-hydroxydopamine rat model of Parkinson’s disease
por: Wu, Kuo-Jen, et al.
Publicado: (2023)

Neurturin overexpression in dopaminergic neurons induces presynaptic and postsynaptic structural changes in rats with chronic 6-hydroxydopamine lesion
por: Reyes-Corona, David, et al.
Publicado: (2017)

Modafinil Improves Catalepsy in a Rat 6-Hydroxydopamine Model of Parkinson’s Disease; Possible Involvement of Dopaminergic Neurotransmission
por: Vajdi-Hokmabad, Reza, et al.
Publicado: (2017)

NOD2 promotes dopaminergic degeneration regulated by NADPH oxidase 2 in 6-hydroxydopamine model of Parkinson’s disease
por: Cheng, Li, et al.
Publicado: (2018)

Both Intracranial and Intravenous Administration of Functionalized Carbon Nanotubes Protect Dopaminergic Neuronal Death from 6-Hydroxydopamine
por: Kim, Ok-Hyeon, et al.
Publicado: (2020)

Berberine chloride pretreatment exhibits neuroprotective effect against 6-hydroxydopamine-induced neuronal insult in rat
por: Negahdar, Feraidoon, et al.
Publicado: (2015)

Neuroprotective Effects of Erucin against 6-Hydroxydopamine-Induced Oxidative Damage in a Dopaminergic-like Neuroblastoma Cell Line
por: Tarozzi, Andrea, et al.
Publicado: (2012)

Dopaminergic neurons show increased low-molecular-mass protein 7 activity induced by 6-hydroxydopamine in vitro and in vivo
por: Mo, Ming-Shu, et al.
Publicado: (2018)

Epothilone B Benefits Nigral Dopaminergic Neurons by Attenuating Microglia Activation in the 6-Hydroxydopamine Lesion Mouse Model of Parkinson’s Disease
por: Yu, Zhongyuan, et al.
Publicado: (2018)

Protective effect of hydroxysafflor yellow A on dopaminergic neurons against 6-hydroxydopamine, activating anti-apoptotic and anti-neuroinflammatory pathways
por: Yang, Xiaomei, et al.
Publicado: (2020)

Suppression of 6-Hydroxydopamine-Induced Oxidative Stress by Hyperoside Via Activation of Nrf2/HO-1 Signaling in Dopaminergic Neurons
por: Kwon, Seung-Hwan, et al.
Publicado: (2019)

Repressing PTBP1 fails to convert reactive astrocytes to dopaminergic neurons in a 6-hydroxydopamine mouse model of Parkinson’s disease
por: Chen, Weizhao, et al.
Publicado: (2022)

Pretreatment With Fragments of Substance-P or With Cholecystokinin Differentially Affects Recovery From Sub-Total Nigrostriatal 6-Hydroxydopamine Lesion
por: Nikolaus, S., et al.
Publicado: (1999)

A case of nontraumatic gas gangrene in a common marmoset (Callithrix jacchus)
por: YASUDA, Masahiko, et al.
Publicado: (2015)

Survey and Experimental Infection of Enteropathogenic Escherichia coli in Common Marmosets (Callithrix jacchus)
por: Hayashimoto, Nobuhito, et al.
Publicado: (2016)

Application of the Physical Disector Principle for Quantification of Dopaminergic Neuronal Loss in a Rat 6-Hydroxydopamine Nigral Lesion Model of Parkinson's Disease
por: Fabricius, Katrine, et al.
Publicado: (2017)

The Cannabigerol Derivative VCE-003.2 Exerts Therapeutic Effects in 6-Hydroxydopamine-Lesioned Mice: Comparison with The Classic Dopaminergic Replacement Therapy
por: Rodríguez-Carreiro, Santiago, et al.
Publicado: (2023)

Novel gastrointestinal disease in common marmosets characterised by duodenal dilation: a clinical and pathological study
por: Mineshige, Takayuki, et al.
Publicado: (2020)

Phytic Acid Protects against 6-Hydroxydopamine-Induced Dopaminergic Neuron Apoptosis in Normal and Iron Excess Conditions in a Cell Culture Model
por: Xu, Qi, et al.
Publicado: (2011)

Chondroitinase ABC reduces dopaminergic nigral cell death and striatal terminal loss in a 6-hydroxydopamine partial lesion mouse model of Parkinson’s disease
por: Fletcher, Edward J. R., et al.
Publicado: (2019)

N-Acetylcysteine Treatment May Compensate Motor Impairments through Dopaminergic Transmission Modulation in a Striatal 6-Hydroxydopamine Parkinson’s Disease Rat Model
por: Caridade-Silva, Rita, et al.
Publicado: (2023)

Pentatrichomonas hominis in laboratory-bred common marmosets
por: Inoue, Takashi, et al.
Publicado: (2015)

The profile of lipid metabolites in urine of marmoset wasting syndrome
por: Yamazaki, Arisa, et al.
Publicado: (2020)

(18)F-FDG-labeled red blood cell PET for blood-pool imaging: preclinical evaluation in rats
por: Matsusaka, Yohji, et al.
Publicado: (2017)

Thioacetamide-induced hepatic fibrosis in the common marmoset
por: Inoue, Takashi, et al.
Publicado: (2018)

Optimization of piggyBac transposon-mediated gene transfer method in common marmoset embryos
por: Kohri, Nanami, et al.
Publicado: (2023)

Marmoset prosociality is intentional
por: Burkart, Judith M., et al.
Publicado: (2020)

Viral Vector-Based Dissection of Marmoset GFAP Promoter in Mouse and Marmoset Brains
por: Shinohara, Yoichiro, et al.
Publicado: (2016)

Protective Effect of the α7 Nicotinic Receptor Agonist PNU-282987 on Dopaminergic Neurons Against 6-Hydroxydopamine, Regulating Anti-neuroinflammatory and the Immune Balance Pathways in Rat
por: Jiang, Ying, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2a6o9n9ql11nmq1h07j08d05o0